Cerebrospinal fluid chitinase-3-like protein 1 level is not an independent predictive factor for the risk of clinical conversion in radiologically isolated syndrome

Abstract

Background:

Younger age, male sex and presence of spinal cord lesion(s) increase the risk of conversion from radiologically isolated syndrome (RIS) to relapsing-remitting multiple sclerosis (RRMS). Elevated cerebrospinal fluid (CSF) chitinase-3-like protein 1 (CHI3L1) levels predict conversion from clinically isolated syndrome (CIS) to RRMS.

Objective:

To evaluate the prognostic value of CSF CHI3L1 in RIS patients for conversion to RRMS.

Methods:

We compared CSF CHI3L1 concentrations in RIS, CIS, RRMS and symptomatic controls (SCs). We analysed the influence of epidemiological, radiological and CSF parameters on the risk of clinical event.

Results:

A total of 211 patients (71 RIS, 48 CIS, 50 RRMS and 42 SC) were included. CSF CHI3L1 levels were lower in RIS than in RRMS and higher in RIS with positive CSF versus negative CSF and SC. The presence of at least one spinal cord lesion was the only independent predictor of faster conversion to RRMS. Association of high CSF CHI3L1 levels, positive CSF (presence of oligoclonal bands and/or an elevated IgG index) or four Barkhof criteria with any spinal cord lesion showed a tendency for reduced mean conversion time.

Conclusion:

CSF CHI3L1 correlates with positive CSF but is not an independent predictor of the risk of conversion from RIS to RRMS.

Keywords

Multiple sclerosis biomarkers cerebrospinal fluid diagnosis prognosis radiologically isolated syndrome

Get full access to this article

View all access options for this article.

References

Okuda

Mowry

Beheshtian

et al . Incidental MRI anomalies suggestive of multiple sclerosis: The radiologically isolated syndrome. Neurology 2009; 72: 800–805.

Polman

Reingold

Banwell

et al . Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292–302.

Okuda

Siva

Kantarci

et al . Radiologically isolated syndrome: 5-year risk for an initial clinical event. PLoS ONE 2014; 9: e90509.

Lebrun

Bensa

Debouverie

et al . Unexpected multiple sclerosis: Follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile. J Neurol Neurosurg Psychiatry 2008; 79: 195–198.

Lebrun

Bensa

Debouverie

et al . Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: Follow-up of 70 patients. Arch Neurol 2009; 66: 841–846.

Okuda

Mowry

Cree

et al . Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. Neurology 2011; 76: 686–692.

Lebrun

Cohen

Pignolet

et al . Interleukin 17 alone is not a discriminant biomarker in early demyelinating spectrum disorders. J Neurol Sci 2016; 368: 334–336.

Rossi

Motta

Studer

et al . Subclinical central inflammation is risk for RIS and CIS conversion to MS. Mult Scler 2015; 21: 1443–1452.

Comabella

Fernandez

Martin

et al . Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis. Brain 2010; 133: 1082–1093.

10.

Canto

Tintore

Villar

et al . Chitinase 3-like 1: Prognostic biomarker in clinically isolated syndromes. Brain 2015; 138: 918–931.

11.

Hinsinger

Galeotti

Nabholz

et al . Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis. Mult Scler 2015; 21: 1251–1261.

12.

Teunissen

Menge

Altintas

et al . Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis. Mult Scler 2013; 19: 1802–1809.

13.

Teunissen

Petzold

Bennett

et al . A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology 2009; 73: 1914–1922.

14.

R Development Core Team. R: A language and environment for statistical computing. Vienna: The R Foundation for Statistical Computing, 2011.

15.

Johansen

Milman

Hansen

et al . Increased serum YKL-40 in patients with pulmonary sarcoidosis – A potential marker of disease activity? Respir Med 2005; 99: 396–402.

16.

Johansen

Stoltenberg

Hansen

et al . Serum YKL-40 concentrations in patients with rheumatoid arthritis: Relation to disease activity. Rheumatology 1999; 38: 618–626.

17.

Koutroubakis

Petinaki

Dimoulios

et al . Increased serum levels of YKL-40 in patients with inflammatory bowel disease. Int J Colorectal Dis 2003; 18: 254–259.

18.

Nordenbaek

Johansen

Halberg

et al . High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement. Scand J Rheumatol 2005; 34: 293–297.

19.

Lee

Da Silva

Cruz

et al . Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu Rev Physiol 2011; 73: 479–501.

20.

Bonneh-Barkay

Bissel

Kofler

et al . Astrocyte and macrophage regulation of YKL-40 expression and cellular response in neuroinflammation. Brain Pathol 2012; 22: 530–546.

21.

Bonneh-Barkay

Wang

Starkey

et al . In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases. J Neuroinflammation 2010; 7: 34.

22.

Canto

Reverter

Morcillo-Suarez

et al . Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis. Mult Scler 2012; 18: 983–990.

23.

Halbgebauer

Huss

Buttmann

et al . Detection of intrathecal immunoglobulin G synthesis by capillary isoelectric focusing immunoassay in oligoclonal band negative multiple sclerosis. J Neurol 2016; 263: 954–960.